Abbott Laboratories has agreed to pay nearly $385 million to settle a civil False Claims Act case with the Justice Department and several states. This case arose from a Cronobacter bacterial contamination at one of its Michigan plants that produces powdered baby formula. The Justice Department had previously closed a parallel criminal investigation, despite initial efforts to pursue felony charges. The civil case alleged that Abbott’s actions led government programs to purchase formula made in unsanitary conditions, risking contamination and compromising product safety. Abbott maintains that the settlement does not imply any fault or liability, and tests on formula from the homes of affected infants were negative for the bacteria. This settlement is part of a trend where corporate cases related to public health have been softened or dismissed by senior Justice Department leaders. Earlier, Alibaba entered a nonprosecution agreement over similar concerns. The closure of Abbott’s criminal case has prompted a congressional inquiry by Senator Adam Schiff.
QUESTION: How might the decision to settle civilly rather than pursue criminal charges impact public trust in the safety of consumer products?
Abbott Labs to pay nearly $385M in case over bacterial contamination at plant
